Ropes & Gray advised Novo Nordisk on the transaction. Novo Nordisk announced an exclusive license agreement with China-based United Laboratories International Holdings Limited and its wholly-owned...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, and Ropes & Gray advised Sarepta Therapeutics. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced a global...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Sanofi on the deal. Sanofi announced a strategic equity investment in Torino, Italy-based Resalis Therapeutics (Resalis Therapeutics). The company plans to use...
You must be a Standard 1 Year member to access this content.
